FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences)
Amicus Therapeutics, Inc. (FOLD) Rockets On Positive Phase 3 Study Data For Rare Disease Drug; Stock Up +21.66% At 11:38AM ET On Wednesday
Allergan Inc. (AGN) Approaches Salix Pharmaceuticals, Ltd. (SLXP) To Fend Off Valeant Pharmaceuticals International (VRX)'s Hostile Bid
FDA Approves Genzyme Corporation (GENZ)'s Gaucher Disease Pill Cerdelga
Baxter International, Inc. (BAX) To Invest $300 Million For Facility Expansion, Will Hire 200 New Workers
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team
Coquí RadioPharmaceuticals's $250 Million Facility To Bring 164-High-Paying Jobs To Alachua
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research
Oncothyreon Inc. (ONTY)'s Lung Cancer Drug EMR 63325-009 Misses Primary Endpoint In Phase 1 Study
Ipsen (IPN.PA) Appoints Cynthia Schwalm As President And CEO Of Ipsen North America
Amgen (AMGN), Bristol-Myers Squibb Company (BMY) On The Prowl For Space In Crowded Cambridge, Massachusetts
Redwood City's Dermira Bags $51 Million, Expands Management Team And Board
Good News For Amgen (AMGN) As Parathyroid Drug AMG 416 Succeeds In Phase 3 Study
Allergan Inc. (AGN) CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International (VRX)
Cubist Pharmaceuticals, Inc. (CBST) Could Be An Acquisition Target For Needy Pfizer Inc. (PFE)
San Diego Startup, Batu Biologics, Achieves Goal In Crowdfunding Campaign
See All News >
Amgen (AMGN), Bristol-Myers Squibb Company (BMY) On The Prowl For Space In Crowded Cambridge, Massachusetts
Best Biotech Employers In America
Redwood City's Dermira Bags $51 Million, Expands Management Team And Board
Good News For Amgen (AMGN) As Parathyroid Drug AMG 416 Succeeds In Phase 3 Study
Allergan Inc. (AGN) CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International (VRX)
Cubist Pharmaceuticals, Inc. (CBST) Could Be An Acquisition Target For Needy Pfizer Inc. (PFE)
San Diego Startup, Batu Biologics, Achieves Goal In Crowdfunding Campaign
Bay Area's HealthQuest Capital Bags $110 Million For Debut Fund With Healthcare, Medtech Focus
Eli Lilly and Company (LLY)-Tied Church Sues Chase Over Mismanaged Trust
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups
FDA Tentatively Approves Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Basaglar™
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal
Children's Drawings May Predict Intelligence Later In Life, King's College London Study
AstraZeneca PLC (AZN) Says U.S. Authorities End Probe Into Clinical Trial Of Star Heart Drug Brilinta
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks
Aspirin's Second Effect: Reduces Inflammation, University of California, San Diego (UCSD) Study
Which Cities Get The Most And Least Sleep?
MediciNova, Inc. Shows Off Positive Phase 2a Study Of Ibudilast
See All News >
//-->